
CPP Investments to Exit Investment in Informatica through Salesforce Transaction
Informatica announced on May 27, 2025, that it has entered into a definitive agreement to be acquired by Salesforce in an all-cash transaction at an equity value of approximately US$8 billion, net of Salesforce's current investment in Informatica.
CPP Investments initially invested in Informatica when it partnered with global investment firm Permira to take the company private. In October 2021, Informatica completed its IPO on the New York Stock Exchange under the ticker symbol INFA. Salesforce's acquisition is expected to generate US$2.7 billion (C$3.7 billion) of net proceeds for CPP Investments upon the completion of the transaction.
"We are pleased with the outcome of this transaction, which is a testament to the hard work, dedication, and innovation of the Informatica team over the last decade. We are proud to have supported the company's successful transformation into a leader in AI-powered cloud data management," said Sam Blaichman, Managing Director and Head of Direct Private Equity at CPP Investments. "Informatica has been a long-standing and successful investment for the CPP Fund, producing solid returns for CPP contributors and beneficiaries. We are confident Informatica will continue to thrive under Salesforce's stewardship and look forward to witnessing its future achievements."
Under the terms of the agreement, Salesforce will acquire all the outstanding shares of common stock of Informatica, and holders of Informatica's Class A and Class B-1 common stock will receive US$25 in cash per share. The transaction is subject to the satisfaction of customary closing conditions, including the receipt of required regulatory approvals.
CPP Investments' Private Equity department invests in a wide range of private equity assets globally, both indirectly through externally managed funds and directly alongside partners, with net assets totaling approximately C$146.5 billion as at March 31, 2025. Private Equity continues to seek return premiums by investing in less-liquid assets and focusing on long-term value creation through commitments to funds, secondary markets, and direct investments in private companies.
About CPP Investments
Canada Pension Plan Investment Board (CPP Investments™) is a professional investment management organization that manages the Canada Pension Plan Fund in the best interests of the more than 22 million contributors and beneficiaries. In order to build diversified portfolios of assets, we make investments around the world in public equities, private equities, real estate, infrastructure and fixed income. Headquartered in Toronto, with offices in Hong Kong, London, Mumbai, New York City, San Francisco, São Paulo and Sydney, CPP Investments is governed and managed independently of the Canada Pension Plan and at arm's length from governments. At March 31, 2025, the Fund totalled C$714.4 billion. For more information, please visit www.cppinvestments.com or follow us on LinkedIn, Instagram or on X @CPPInvestments.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Canada News.Net
an hour ago
- Canada News.Net
Birkenstock, Bugaboo, Coach thrive as rich Americans absorb hikes
LONDON, U.K.: For now, America's wealthier consumers appear unfazed by price increases on high-end products, from Birkenstock sandals to Bugaboo strollers, even as tariffs and economic uncertainty push brands to raise prices. German footwear brand Birkenstock has seen "tremendously strong" demand since introducing higher prices on July 1 to offset U.S. import tariffs, CEO Oliver Reichert told analysts this week. "We saw no pushback or cancellations," he said. The resilience mirrors trends across several premium brands. Bugaboo, the Dutch maker of strollers, high chairs, and playpens retailing for more than US$1,000, raised prices by $50 to $300 in May. "In general, we did not see any pushback," said Jeanelle Teves, Bugaboo's chief commercial officer for North America, noting retailers were "open and accepting" of the changes. Coach handbags have also remained popular, with parent company Tapestry reporting 4.6 million new North American customers this year, many from Gen Z and millennial demographics. CEO Joanne Kuvoiserat said the brand expects to maintain profit margins despite tariff pressures. Ralph Lauren likewise raised its annual revenue forecast as shoppers snapped up items like its $398 Polo Bear sweaters. However, CEO Patrice Louvet cautioned that price sensitivity in the second half remains a key unknown. Bank of America data supports the picture of steady luxury spending. The bank reported that middle—and upper-income cardholders spent more in July than a year earlier, even as spending by lower-income customers stayed flat. The bank noted that lower-income households account for only 15 percent of U.S. consumer spending, meaning overall demand could remain strong if higher-income spending holds up. However, some signs of caution are emerging. Procter & Gamble, maker of Tide detergent, noted that even wealthier consumers are becoming more selective in their purchases. Bugaboo manufactures in China and sells through retailers including Target, Nordstrom, and Bloomingdale's, as well as smaller independent stores. Coach's popular Tabby shoulder bag sells for $350, while Ralph Lauren's luxury apparel continues to command high prices. As brands watch the second half of the year unfold, the big question remains whether affluent shoppers will keep absorbing price hikes or begin to pull back in the face of a "broader pricing environment," Louvet said.


Globe and Mail
2 hours ago
- Globe and Mail
1 Stock Down 40% This Year to Buy and Hold
Key Points Novo Nordisk's shares have been trending downward due to clinical setbacks and underwhelming results. However, the company has some potential catalysts on the way that could jolt its stock price. Novo Nordisk looks attractive given its lineup and pipeline, especially at current levels. 10 stocks we like better than Novo Nordisk › Novo Nordisk (NYSE: NVO) first earned U.S. approval for its now-famous weight management medicine Wegovy in June 2021. That marked the beginning of a strong run for the company on the stock market. However, the Denmark-based drugmaker has given up most of these gains over the past year; the stock is down by 40% since January alone. Despite its recent misfortunes, Novo Nordisk's shares could still deliver strong returns to patient investors. Here's why. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » NVO Total Return Level data by YCharts. The weight management opportunity Novo Nordisk primarily develops medicines for diabetes and, in recent years, weight management. Its stock has plunged over the past year because its financial results haven't been as impressive as the market had hoped. It also faced some clinical setbacks, while its biggest rival in its core markets, Eli Lilly, earned some important wins. However, there's more to the story. The market for anti-obesity medications could grow at an incredibly rapid rate. Some analysts estimate that it will be worth $150 billion by 2035, compared to $15 billion last year. Novo Nordisk still has one of the deepest pipelines in the industry. In fact, it's challenging to find a company other than Eli Lilly that has more promising products. Recently, Novo Nordisk expanded its pipeline through various licensing deals. Here's one more thing that recently broke its way: Eli Lilly's oral GLP-1 candidate, orforglipron, did not perform nearly as well as expected in a phase 3 study. This opens the door for Novo Nordisk to catch up to its longtime rival. The company's oral version of Wegovy is currently awaiting approval from regulators in the U.S. The oral version led to an average weight reduction of 13.6% in a phase 3 clinical trial, slightly higher than the 12.4% that orforglipron recently posted in its late-stage study. While it's always hard to compare across clinical trials, the data at the very least suggests that oral Wegovy is comparable to orforglipron -- but only the former drug is closing in on approval. Novo Nordisk also has yet another promising anti-obesity candidate in phase 3 studies, amycretin, which the Denmark-based pharmaceutical giant is testing in both subcutaneous and oral formulations. Why is the race to develop an oral weight loss option so important? Pills are easier and cheaper to manufacture, store, and transport. So, compared to injectable weight loss therapies, oral versions would allow drugmakers to produce them more cost-effectively and to expand the reach of weight loss therapies. On top of that, some patients are strongly averse to needles. Because the current leading weight management drugs are administered subcutaneously, an oral option would likely take a decent share of the market. Novo Nordisk is likely to be first to market. And the company could follow up that win with another oral product in amycretin. The price is right Let's go back to Novo Nordisk's recent and disappointing financial results. In the first half of the year, revenue rose by 16% year over year to 154.9 billion Danish kroner ($24.2 billion), while net profit came in at 55.5 billion DKK ($8.7 billion). Perhaps that's not quite what the market expected to see, but these are still excellent results for a pharmaceutical giant -- most drugmakers of that size would be happy to grow their revenue at high-single-digit or low-double-digit rates. Meanwhile, the stock appears reasonably valued, trading at 13 times forward earnings, compared to the healthcare industry 's average of 16.2. What's the verdict? Novo Nordisk looks attractive at current levels, given the company's strong pipeline in weight management and a lineup that continues to deliver consistent profits. Despite recent setbacks, the stock is well-positioned to deliver excellent results over the long term. Should you invest $1,000 in Novo Nordisk right now? Before you buy stock in Novo Nordisk, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Novo Nordisk wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $668,155!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,106,071!* Now, it's worth noting Stock Advisor's total average return is 1,070% — a market-crushing outperformance compared to 184% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 13, 2025


CTV News
5 hours ago
- CTV News
Duty-free shops facing ‘full-blown crisis' with no relief in sight
John Slipp is seen at his closed duty-free store, at the Canada-U.S. border crossing between Woodstock, N.B., and Houlton, Maine, on Thursday, Aug. 14, 2025. THE CANADIAN PRESS/Stephen MacGillivray John Slipp took over his father's duty-free store in 1994, which had been started more than a decade earlier. This month, he closed the Woodstock Duty Free Shop Inc. as lower traffic at the U.S.-Canada border dealt the final blow to a business already weakened by the COVID-19 pandemic. Now, at 59, Slipp says he will have to find another source of income and is advocating for more government support for stores like his. Fewer Canadians have been heading south in recent months in response to U.S. President Donald Trump's trade war with Canada, his comments about annexing the country and because of fears among travellers about treatment at the border. In the duty-free industry, Slipp said less border traffic directly correlates to fewer sales. 'It was very difficult. The business had many good years. I certainly didn't want to be in the position of calling an end to a business career, giving up, calling it quits, both personally and in terms of my late father,' Slipp said. At the store's peak in the early 2000s, Slipp said there were about 15 people on staff. In March 2020, he said he laid off four people and reopened after the pandemic with two employees. Late in the summer of 2021, Slipp said duty-free stores were 'all starting from zero to rebuild again.' By the end of 2024, his business was still down about one-fifth from where it was in 2019. Then Trump returned to the White House. From January to April this year, things got worse for Slipp's store, and he ultimately decided to close based on declining sales and traffic numbers. 'Just realizing that even after the U.S. administration changes down the road, in our industry, we do not expect the border traffic to change overnight as a result of that. We believe it's going to take years,' he said. Recent figures from Statistics Canada noted that return trips from the U.S. dropped again in July as Canadians continue to shun travel to the U.S. The number of Canadian residents returning from the U.S. by automobile was down 36.9 per cent on an annual basis in July, marking the seventh consecutive month of year-over-year declines. Barbara Barrett, executive director of the Frontier Duty Free Association, said the stores her association represents have been feeling the decline in traffic for months. 'I would describe our industry as being in a full-blown crisis, and we've been saying that for a number of months now,' she said. Sales at duty-free stores have fallen between 40 and 50 per cent year-over-year across the country since late January, with some remote crossings reporting annual declines of up to 80 per cent, the association said. Barrett added that duty-free stores are often a microcosm of what is happening at the border. 'This should be our busy season during the summer, but it is not; it is pandemic-level traffic in the parking lots, and it has led to one store closing in the east. We are unfortunately afraid that we will likely see more closures as we draw to the end of the summer,' she said. Unlike airport stores, which are often owned by international companies, Barrett noted all of the land border stores are independently owned and are often family-run businesses. While Canadians shun U.S. trips, travel expert Claire Newell said many are opting for domestic and other international destinations. 'We live in a country where it's still very expensive to travel domestically. And while there are many people who are choosing to travel within Canada, we also see more people heading to popular destinations,' she said. She said she doesn't see Canadians changing their travel habits back to normal until there is a trade deal 'that feels fair.' As lower border traffic weighs on the industry, Barrett said she is advocating for 'small regulatory changes.' 'We have some taxes on our products that, believe it or not, in a tax- and duty-free industry that our U.S. competitors don't have. So we're asking for those to be changed so we can be more competitive,' she said. 'Also, we're asking to qualify for some of these tariff relief programs or pandemic-level supports along the lines of what they did during the pandemic with wage subsidy or rent subsidy.' Barrett said the government is the landlord for many duty-free stores and said a rent deferral or subsidy would help the industry until travel patterns normalize. She added that there have been conversations between her organization and senior government officials. Barrett said those officials agreed the association was putting forward 'small asks' to support the industry. An Aug. 2 release announcing the Woodstock Duty Free Shop's closure mentioned that the federal and provincial governments had promised tariff relief support programs to help businesses impacted by trade tensions. 'I pinned a lot of hopes on those when both levels of government made those announcements. I was reminded of the pandemic support programs,' Slipp said, adding that his business had benefited from such programs. His attention has now turned to advocating for rent deferral programs for duty-free shops renting land from either the federal government or from a bridge authority as well as loan programs for duty-free stores. When he looks at the future of the industry, he said the prospects 'are not bright.' 'I'm grieving the loss of my business, but I'm also accepting the reality that the business environment has changed and there is nothing in the bag of tricks that would suggest positive changes in this industry in the short to medium term,' Slipp said. 'I'm feeling bad that I was not able to succeed in the end and that I am having to lay to rest this business that my father and I have built and spent so many years working so hard on.' This report by The Canadian Press was first published Aug. 17, 2025. Daniel Johnson, The Canadian Press